Eclipse Bioinnovations: Hallie Kuhn

Mar 17, 2022

Hallie Kuhn has joined the board of director of Eclipse Bioinnovations as part of the company's recent Series A financing. He is the VP of science and technology at Alexandria Real Estate Equities and Alexandria Venture Investments, which co-led the round.

Breaking News

T2 Biosystems, Vanderbilt University Medical Center Partner on Prospective Bacterial Sepsis Dx Study
Foundation Medicine Blood Test Gets FDA Approval as CDx for Pfizer's Braftovi in Colorectal Cancer
Acutis Diagnostics Gets FDA Emergency Use Authorization for COVID-19 RT-PCR Test
In Brief This Week: HTG Molecular, Prenetics, DiaSorin, DermTech, NanoString Technologies, More
Single-Cell Atlas of Human Lung Highlights Differences Between Healthy, Diseased States

The Scan

Foxtail Millet Pangenome, Graph-Based Reference Genome

Researchers in Nature Genetics described their generation of a foxtail millet pangenome, which they say can help in crop trait improvement.

Protein Length Distribution Consistent Across Species

An analysis in Genome Biology compares the lengths of proteins across more than 2,300 species, finding similar distributions.

Novel Genetic Loci Linked to Insulin Resistance in New Study

A team reports in Nature Genetics that it used glucose challenge test data to home in on candidate genes involved in in GLUT4 expression or trafficking.

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.